Many Bright Ideas Technologies Inc MBGNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.11
- Bid/Ask
- $0.01 / $0.11
- Market Cap
- $172,578.38
- Volume/Avg
- 1,000 / 600
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Many Bright Ideas Technologies Inc is a Canada-based life science company. It focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with early-stage non-small-cell lung cancer.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 7
- Website
- http://www.medbiogene.com
Valuation
|
Metric
|
MBGNF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MBGNF
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.05 |
Interest Coverage | — |
Quick Ratio
MBGNF
Profitability
|
Metric
|
MBGNF
|
|---|---|
Return on Assets (Normalized) | −649.64% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MBGNF
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Btkywtryg | Pzvc | $220.6 Bil | |
DHR
| Danaher Corp | Cytwppkby | Tvhwg | $184.8 Bil | |
A
| Agilent Technologies Inc | Kwygdfxwbw | Fyvyc | $41.8 Bil | |
IQV
| IQVIA Holdings Inc | Wpzpdbn | Xhgxkj | $41.5 Bil | |
IDXX
| IDEXX Laboratories Inc | Rkwfywbx | Rbvzkm | $41.4 Bil | |
MTD
| Mettler-Toledo International Inc | Hpbykyhh | Xxtwbw | $27.6 Bil | |
ICLR
| Icon PLC | Xcfzcfqh | Hmpqjh | $26.1 Bil | |
WAT
| Waters Corp | Txqdjwhsg | Srxj | $19.2 Bil | |
ILMN
| Illumina Inc | Qtrqkll | Drvzh | $17.6 Bil | |
LH
| Laboratory Corp of America Holdings | Fgzmntdvk | Yjslft | $17.4 Bil |